1 |
Levodopa/carbidopa (sinemet) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
2 |
Sinemet |
- |
- |
- |
- |
006 [1] 6 💬 |
3 |
Sinemet (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
4 |
Sinemet (comparator) |
- |
- |
- |
- |
006 [1] 6 💬 |
5 |
Sinemet (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
6 |
Sinemet 10-100 |
- |
- |
- |
- |
006 [1] 6 💬 |
7 |
Sinemet 100 mg + 25 mg compresse |
- |
- |
- |
- |
006 [1] 6 💬 |
8 |
Sinemet 125 |
- |
- |
- |
- |
006 [1] 6 💬 |
9 |
Sinemet 125 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
10 |
Sinemet 200mg/50mg |
- |
- |
- |
- |
006 [1] 6 💬 |
11 |
Sinemet 25-100 |
- |
- |
- |
- |
006 [1] 6 💬 |
12 |
Sinemet 25/100 |
- |
- |
- |
- |
006 [1] 6 💬 |
13 |
Sinemet cr |
- |
- |
- |
- |
006 [1] 6 💬 |
14 |
Sinemet cr 25mg-100mg extended-release tablet |
- |
- |
- |
- |
006 [1] 6 💬 |
15 |
Sinemet ir |
- |
- |
- |
- |
006 [1] 6 💬 |
16 |
Sinemet plus |
- |
- |
- |
- |
006 [1] 6 💬 |
17 |
Sinemet plus (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
18 |
Sinemet*50cpr 100mg+25mg |
- |
- |
- |
- |
006 [1] 6 💬 |
19 |
Sinemet-plus tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
20 |
Sinemet® |
- |
- |
- |
- |
006 [1] 6 💬 |
21 |
Sinemet® 100/25 |
- |
- |
- |
- |
006 [1] 6 💬 |
22 |
Sinemet® 100/25 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
23 |
Sinemet® controlled release (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
24 |
Sinemet® cr |
- |
- |
- |
- |
006 [1] 6 💬 |
25 |
Sinemet® cr 100/25 |
- |
- |
- |
- |
006 [1] 6 💬 |
26 |
Sinemet® plus 25 mg/100 mg tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
27 |
Sinemet®-plus tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
28 |
Sinemet®25-100 |
- |
- |
- |
- |
006 [1] 6 💬 |